U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07431398) titled 'Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease' on Feb. 18.
Brief Summary: This clinical trial is a study to evaluate the pharmacokinetics of the tablet formulation Pociredir in fasted and fed state participants with Sickle Cell Disease (SCD).
Study Start Date: Dec. 13, 2025
Study Type: INTERVENTIONAL
Condition:
Sickle Cell Disease
Intervention:
DRUG: Pociredir
Pociredir tablet formulation
Recruitment Status: RECRUITING
Sponsor: Fulcrum Therapeutics
Published by HT Digital Content Services with permission from Health Daily Digest....